Rational Advisors LLC Acquires Shares of 4,100 Express Scripts Holding Company (ESRX)
Rational Advisors LLC acquired a new stake in shares of Express Scripts Holding Company (NASDAQ:ESRX) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 4,100 shares of the company’s stock, valued at approximately $260,000.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Nordea Investment Management AB increased its stake in shares of Express Scripts Holding by 1.4% during the second quarter. Nordea Investment Management AB now owns 7,116,445 shares of the company’s stock valued at $454,314,000 after acquiring an additional 97,953 shares during the period. First Trust Advisors LP increased its stake in shares of Express Scripts Holding by 25.3% during the second quarter. First Trust Advisors LP now owns 708,955 shares of the company’s stock valued at $45,260,000 after acquiring an additional 143,163 shares during the period. Lazard Asset Management LLC grew its position in Express Scripts Holding by 81.8% in the second quarter. Lazard Asset Management LLC now owns 112,666 shares of the company’s stock worth $7,192,000 after buying an additional 50,707 shares during the last quarter. Legal & General Group Plc grew its position in Express Scripts Holding by 1.7% in the second quarter. Legal & General Group Plc now owns 3,654,765 shares of the company’s stock worth $233,323,000 after buying an additional 62,263 shares during the last quarter. Finally, Marco Investment Management LLC acquired a new position in Express Scripts Holding in the second quarter worth approximately $1,797,000. Institutional investors and hedge funds own 89.34% of the company’s stock.
In related news, Director Woodrow A. Myers, Jr. sold 3,900 shares of the business’s stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $63.93, for a total transaction of $249,327.00. Following the completion of the sale, the director now directly owns 11,500 shares of the company’s stock, valued at $735,195. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Timothy C. Wentworth purchased 8,000 shares of the company’s stock in a transaction that occurred on Tuesday, October 31st. The shares were acquired at an average cost of $61.13 per share, with a total value of $489,040.00. Following the completion of the purchase, the chief executive officer now owns 98,628 shares of the company’s stock, valued at $6,029,129.64. The disclosure for this purchase can be found here. Insiders have sold 6,284 shares of company stock worth $397,421 over the last quarter. 0.68% of the stock is owned by company insiders.
COPYRIGHT VIOLATION NOTICE: This piece of content was first reported by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another publication, it was stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/rational-advisors-llc-acquires-shares-of-4100-express-scripts-holding-company-esrx/1717938.html.
Express Scripts Holding Company (NASDAQ:ESRX) traded down $0.10 during trading hours on Tuesday, reaching $61.32. 523,439 shares of the company’s stock were exchanged, compared to its average volume of 4,090,482. The firm has a market capitalization of $34,790.00, a price-to-earnings ratio of 9.06, a PEG ratio of 0.91 and a beta of 0.88. Express Scripts Holding Company has a 52-week low of $55.80 and a 52-week high of $77.50. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.61 and a current ratio of 0.73.
Express Scripts Holding (NASDAQ:ESRX) last released its quarterly earnings results on Tuesday, October 24th. The company reported $1.90 EPS for the quarter, meeting the Zacks’ consensus estimate of $1.90. The firm had revenue of $24.68 billion for the quarter, compared to analyst estimates of $25.68 billion. Express Scripts Holding had a net margin of 3.64% and a return on equity of 25.46%. The company’s revenue for the quarter was down 2.9% compared to the same quarter last year. During the same period in the previous year, the business earned $1.74 earnings per share. analysts expect that Express Scripts Holding Company will post 7.01 earnings per share for the current fiscal year.
ESRX has been the topic of several recent research reports. Zacks Investment Research upgraded shares of Express Scripts Holding from a “hold” rating to a “buy” rating and set a $64.00 price target on the stock in a research report on Monday, October 16th. ValuEngine upgraded shares of Express Scripts Holding from a “hold” rating to a “buy” rating in a research report on Monday, October 2nd. Jefferies Group LLC set a $72.00 price target on shares of Express Scripts Holding and gave the stock a “buy” rating in a research report on Tuesday, August 29th. Robert W. Baird restated a “hold” rating and issued a $56.00 price target on shares of Express Scripts Holding in a research report on Friday, September 1st. Finally, Mizuho set a $67.00 price objective on shares of Express Scripts Holding and gave the stock a “hold” rating in a research note on Tuesday, October 24th. Seven research analysts have rated the stock with a sell rating, ten have given a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $69.53.
Express Scripts Holding Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with Analyst Ratings Network's FREE daily email newsletter.